Jakob Shepard
reacted to and commented on
By Danilo
Hey, mooers! Here are things you need to know before the opening bell:
- U.S. stock futures were higher in early morning trading on Tuesday after the Dow Jones Industrial Average and S&P 500 notched new record closes on the first trading day of 2022.
- The iPhone maker's shares closed below the milestone after a 41% jump since the beginning of 2021.
Market Snapshot
U.S. stock futures were higher in early morning trading on ...
Hey, mooers! Here are things you need to know before the opening bell:
- U.S. stock futures were higher in early morning trading on Tuesday after the Dow Jones Industrial Average and S&P 500 notched new record closes on the first trading day of 2022.
- The iPhone maker's shares closed below the milestone after a 41% jump since the beginning of 2021.
Market Snapshot
U.S. stock futures were higher in early morning trading on ...
+1
40
7
wow wish I would have invested back when they were started
1
not too shabby
Market trend
Account P/L
Position details
No transaction on the day
Market trend
Account P/L
Position details
No transaction on the day
loading...
Jakob Shepard
liked
$Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X Shares(UBOT.US$ anyone else seeing what I'm tasting.....the future is being slow roasted..,
1
Jakob Shepard
reacted to
Daily Poll
On Monday, $Moderna(MRNA.US$ stock shot up 17.1%, the biggest one-day gain in nearly nine months, to a record close of $484.47. The company’s valuation is “unjustifiable on a fundamental basis,” said analyst Geoff Meacham, he suggests the stock should be priced roughly 75% below current levels.
The stock price of $BioNTech(BNTX.US$ also increased 14.97% yesterday, going from a previous close of $389.01 to $447.23.
Shares of clinical-stage vaccine developer Vaxa...
On Monday, $Moderna(MRNA.US$ stock shot up 17.1%, the biggest one-day gain in nearly nine months, to a record close of $484.47. The company’s valuation is “unjustifiable on a fundamental basis,” said analyst Geoff Meacham, he suggests the stock should be priced roughly 75% below current levels.
The stock price of $BioNTech(BNTX.US$ also increased 14.97% yesterday, going from a previous close of $389.01 to $447.23.
Shares of clinical-stage vaccine developer Vaxa...
29
9